- ISIN
- US65487U1088
- CUSIP
- 65487U108
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jul 10, 2020
Highlights
- Market Cap
- $149.53M
- Enterprise Value
- $204.25M
- EPS (TTM)
- -$1.35
- Gross Profit (TTM)
- -$2.26M
- EBITDA (TTM)
- -$103.84M
- Year Range
- $1.70 - $3.72
- Target Price
- $21.60
- ROA (TTM)
- -26.86%
- ROE (TTM)
- -34.96%
- Avg. Volume (1M)
- 807K
- Avg. Volume Value (1M)
- $2.23M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NKTX Performance Chart
Nkarta, Inc. (NKTX) is up 13.0% since the beginning of the year. At $2 per share, NKTX is trading 43.8% below its 52-week high of $4. Investors who bought $1,000 worth of NKTX shares 5 years ago would now be looking at an investment worth $66.
Loading charts...
Compare this symbol against anything
Returns By Period
Nkarta, Inc. (NKTX) has returned 12.97% so far this year and -1.42% over the past 12 months.
Nkarta, Inc.
- 1D
- -2.79%
- 1M
- -35.09%
- 6M
- -5.86%
- YTD
- 12.97%
- 1Y
- -1.42%
- 3Y*
- -2.57%
- 5Y*
- -41.97%
- 10Y*
- —
- ALL TIME*
- -41.68%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
NKTX Monthly Returns History
Based on dividend-adjusted daily data since Jul 10, 2020, NKTX's average daily return is 0.00%, while the average monthly return is -0.33%.
Historically, 40% of months were positive and 60% were negative. The best month was Dec 2023 with a return of +150.0%, while the worst month was Jul 2020 at -53.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.
On a daily basis, NKTX closed higher 45% of trading days. The best single day was Apr 25, 2022 with a return of +140.9%, while the worst single day was Jun 27, 2023 at -38.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 20.00% | 21.62% | -21.85% | 31.28% | 17.33% | -12.92% | -26.15% | 12.97% | |||||
| 2025 | -6.02% | -25.21% | 5.14% | 15.22% | -17.92% | -4.60% | 30.72% | -2.30% | -2.36% | 1.93% | -10.43% | -2.12% | -25.70% |
| 2024 | 36.97% | 33.63% | -10.51% | -38.21% | 1.65% | -12.96% | 8.80% | -17.42% | -14.88% | -31.86% | -6.82% | -13.24% | -62.27% |
| 2023 | -11.02% | -21.20% | -15.48% | 39.44% | -6.67% | -52.60% | 4.57% | -24.89% | -19.19% | 46.04% | 30.05% | 150.00% | 10.18% |
| 2022 | -35.44% | -8.58% | 25.61% | 62.04% | -21.75% | -14.62% | 9.66% | 6.51% | -8.55% | -4.18% | -32.75% | -29.36% | -60.98% |
| 2021 | -35.48% | 22.95% | -32.53% | -3.19% | -23.55% | 30.14% | 0.22% | 1.83% | -14.01% | -43.62% | 1.34% | -3.40% | -75.03% |
Benchmark Metrics
Nkarta, Inc. has an annualized alpha of -20.31%, beta of 1.50, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since July 10, 2020.
- This stock participated in 212.48% of S&P 500 Index downside but only -11.92% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -20.31%
- Beta
- 1.50
- R²
- 0.05
- Upside Capture
- -11.92%
- Downside Capture
- 212.48%
Return for Risk
Risk / Return Rank
NKTX ranks 43 for risk / return — above 43% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Nkarta, Inc. (NKTX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NKTX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.47 | ||
| Sortino ratioReturn per unit of downside risk | -1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.25 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.09 | 2.00 | -2.09 |
| Martin ratioReturn relative to average drawdown | -0.18 | 8.49 | -8.68 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Nkarta, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Nkarta, Inc. was 98.27%, occurring on Oct 2, 2023. The portfolio has not yet recovered.
The current Nkarta, Inc. drawdown is 97.24%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-98.27%Oct 2023 | 2y 9mo | — | 5y 7moDec 2020 - now | — |
-57.04%Aug 2020 | 1mo 1d | 4mo | 5mo 1dJul 2020 - Dec 2020 | — |
-12.82%Dec 2020 | 7d | 4d | 11dDec 2020 - Dec 2020 | — |
Drawdown Indicators
| NKTX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.27% | -56.78% | -41.49% |
Max Drawdown (1Y)Largest decline over 1 year | -43.05% | -9.10% | -33.95% |
Max Drawdown (3Y)Largest decline over 3 years | -91.28% | -18.90% | -72.38% |
Max Drawdown (5Y)Largest decline over 5 years | -96.62% | -25.43% | -71.19% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.24% | -1.58% | -95.66% |
Average DrawdownAverage peak-to-trough decline | -82.72% | -10.70% | -72.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.12% | 2.14% | +17.98% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Nkarta, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Nkarta, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NKTX in comparison with other companies in the Biotechnology industry. Currently, NKTX has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NKTX
Add Nkarta, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NKTX